Biocon Limited (NSE:BIOCON)

Biocon Statistics

Total Valuation

Biocon has a market cap or net worth of INR 513.63 billion. The enterprise value is 680.47 billion.

Market Cap	513.63B
Enterprise Value	680.47B

Important Dates

The next estimated earnings date is Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	Jul 4, 2025

Share Statistics

Biocon has 1.33 billion shares outstanding. The number of shares has increased by 3.69% in one year.

Current Share Class	1.33B
Shares Outstanding	1.33B
Shares Change (YoY)	+3.69%
Shares Change (QoQ)	+7.64%
Owned by Insiders (%)	55.87%
Owned by Institutions (%)	23.96%
Float	588.71M

Valuation Ratios

The trailing PE ratio is 98.55 and the forward PE ratio is 52.96. Biocon's PEG ratio is 1.06.

PE Ratio	98.55
Forward PE	52.96
PS Ratio	3.12
PB Ratio	1.55
P/TBV Ratio	n/a
P/FCF Ratio	26.27
P/OCF Ratio	12.35
PEG Ratio	1.06

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.73, with an EV/FCF ratio of 34.80.

EV / Earnings	140.16
EV / Sales	4.13
EV / EBITDA	19.73
EV / EBIT	39.90
EV / FCF	34.80

Financial Position

The company has a current ratio of 1.16, with a Debt / Equity ratio of 0.50.

Current Ratio	1.16
Quick Ratio	0.72
Debt / Equity	0.50
Debt / EBITDA	4.79
Debt / FCF	8.46
Interest Coverage	1.75

Financial Efficiency

Return on equity (ROE) is 2.55% and return on invested capital (ROIC) is 2.29%.

Return on Equity (ROE)	2.55%
Return on Assets (ROA)	1.78%
Return on Invested Capital (ROIC)	2.29%
Return on Capital Employed (ROCE)	3.67%
Revenue Per Employee	10.10M
Profits Per Employee	297,579
Employee Count	16,315
Asset Turnover	0.27
Inventory Turnover	1.23

Taxes

In the past 12 months, Biocon has paid 1.48 billion in taxes.

Income Tax	1.48B
Effective Tax Rate	16.29%

Stock Price Statistics

The stock price has increased by +9.10% in the last 52 weeks. The beta is 0.24, so Biocon's price volatility has been lower than the market average.

Beta (5Y)	0.24
52-Week Price Change	+9.10%
50-Day Moving Average	381.04
200-Day Moving Average	357.19
Relative Strength Index (RSI)	47.16
Average Volume (20 Days)	3,778,526

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biocon had revenue of INR 164.76 billion and earned 4.86 billion in profits. Earnings per share was 3.91.

Revenue	164.76B
Gross Profit	98.71B
Operating Income	17.06B
Pretax Income	9.11B
Net Income	4.86B
EBITDA	33.89B
EBIT	17.06B
Earnings Per Share (EPS)	3.91

Balance Sheet

The company has 61.04 billion in cash and 165.36 billion in debt, giving a net cash position of -104.32 billion or -78.17 per share.

Cash & Cash Equivalents	61.04B
Total Debt	165.36B
Net Cash	-104.32B
Net Cash Per Share	-78.17
Equity (Book Value)	330.55B
Book Value Per Share	209.35
Working Capital	25.27B

Cash Flow

In the last 12 months, operating cash flow was 41.59 billion and capital expenditures -22.04 billion, giving a free cash flow of 19.55 billion.

Operating Cash Flow	41.59B
Capital Expenditures	-22.04B
Free Cash Flow	19.55B
FCF Per Share	14.65

Margins

Gross margin is 59.91%, with operating and profit margins of 10.35% and 2.95%.

Gross Margin	59.91%
Operating Margin	10.35%
Pretax Margin	5.53%
Profit Margin	2.95%
EBITDA Margin	20.57%
EBIT Margin	10.35%
FCF Margin	11.87%

Dividends & Yields

This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 0.13%.

Dividend Per Share	0.50
Dividend Yield	0.13%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	13.99%
Buyback Yield	-3.69%
Shareholder Yield	-3.56%
Earnings Yield	0.95%
FCF Yield	3.81%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on June 12, 2019. It was a forward split with a ratio of 2.

Last Split Date	Jun 12, 2019
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	7